HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Whitney A Spannuth Selected Research
Whitney A Spannuth Research Topics
Disease
21
Neoplasms (Cancer)
12/2010 - 06/2007
17
Ovarian Neoplasms (Ovarian Cancer)
08/2010 - 06/2007
9
Carcinoma (Carcinomatosis)
08/2009 - 06/2007
6
Ovarian Epithelial Carcinoma
03/2010 - 03/2007
2
Endometrial Neoplasms (Endometrial Cancer)
12/2010 - 12/2007
1
Adenocarcinoma
12/2010
1
Venous Thromboembolism
10/2010
1
Thromboembolism
10/2010
1
Necrosis
10/2007
1
Genomic Instability
07/2007
1
Inflammation (Inflammations)
06/2007
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2007
Drug/Important Bio-Agent (IBA)
8
Docetaxel (Taxotere)
FDA Link
12/2010 - 06/2007
6
Proteins (Proteins, Gene)
FDA Link
03/2010 - 07/2007
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2010 - 12/2007
5
Biological Products
IBA
12/2010 - 12/2007
4
Small Interfering RNA (siRNA)
IBA
08/2010 - 11/2007
3
Topotecan (Hycamtin)
FDA Link
Generic
04/2010 - 03/2007
3
Platinum
IBA
03/2010 - 03/2007
2
Estrogen Receptors
IBA
12/2010 - 05/2009
2
Progesterone Receptors (Progesterone Receptor)
IBA
12/2010 - 05/2009
2
Monoclonal Antibodies
IBA
08/2010 - 11/2008
2
Focal Adhesion Protein-Tyrosine Kinases
IBA
05/2010 - 11/2007
2
Norepinephrine (Noradrenaline)
FDA Link
Generic
05/2010 - 11/2007
2
Epinephrine (Adrenaline)
FDA Link
Generic
05/2010 - 11/2007
2
Hormones (Hormone)
IBA
05/2010 - 05/2009
2
Proliferating Cell Nuclear Antigen (PCNA)
IBA
08/2009 - 11/2008
2
Cisplatin (Platino)
FDA Link
Generic
06/2009 - 05/2007
2
1,2-oleoylphosphatidylcholine (DOPC)
IBA
06/2009 - 03/2008
2
Messenger RNA (mRNA)
IBA
05/2009 - 12/2008
2
Liposomes (Liposome)
IBA
03/2008 - 11/2007
1
EphB4 Receptor
IBA
08/2010
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
08/2010
1
Adrenergic Agents (Adrenergic Drugs)
IBA
05/2010
1
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
04/2010
1
pazopanib
FDA Link
04/2010
1
Complement System Proteins (Complement)
IBA
03/2010
1
farletuzumab
IBA
03/2010
1
Folate Receptor 1
IBA
03/2010
1
Collagen
IBA
05/2009
1
Progestins (Progestagens)
IBA
05/2009
1
Estrogen Receptor alpha
IBA
05/2009
1
Estrogens (Estrogen)
FDA Link
05/2009
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
03/2009
1
Ramucirumab
IBA
03/2009
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
03/2009
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
03/2009
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
12/2008
1
DNA (Deoxyribonucleic Acid)
IBA
12/2008
1
Integrin beta3 (GPIIIa)
IBA
11/2008
1
Integrin alphaVbeta3
IBA
11/2008
1
etaracizumab
IBA
11/2008
1
tozasertib
IBA
09/2008
1
Aurora Kinases
IBA
09/2008
1
Histones (Histone)
IBA
09/2008
1
Protein Glutamine gamma Glutamyltransferase 2
IBA
07/2008
1
Histocompatibility Antigens Class I
IBA
06/2008
1
beta 2-Microglobulin (beta 2 Microglobulin)
IBA
06/2008
1
tapasin
IBA
06/2008
1
taxane
IBA
03/2008
1
Interleukin-8 (Interleukin 8)
IBA
03/2008
1
Cytokines
IBA
03/2008
1
Bevacizumab (Avastin)
FDA Link
12/2007
1
TAE226
IBA
11/2007
1
Adrenergic Receptors (Adrenergic Receptor)
IBA
11/2007
1
Isoproterenol (Isoprenaline)
FDA Link
Generic
11/2007
1
Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
IBA
11/2007
1
Matrix Metalloproteinases (MMPs)
IBA
11/2007
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
10/2007
1
AC 7700
IBA
10/2007
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
07/2007
1
Aurora Kinase A
IBA
07/2007
1
NF-kappa B (NF-kB)
IBA
06/2007
1
Curcumin
IBA
06/2007
1
Transcription Factors (Transcription Factor)
IBA
06/2007
1
Carboplatin (JM8)
FDA Link
Generic
05/2007
1
Paclitaxel (Taxol)
FDA Link
Generic
05/2007
Therapy/Procedure
15
Therapeutics
12/2010 - 03/2007
4
Drug Therapy (Chemotherapy)
08/2009 - 10/2007
1
Minimally Invasive Surgical Procedures
10/2010
1
Operative Time
10/2010
1
Biological Therapy
04/2010
1
Combination Drug Therapy (Combination Chemotherapy)
03/2010
1
Aftercare (After-Treatment)
03/2009